+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 70Years
FEMALE
ID06341907

Using Minimal Residual Disease Testing and Personalized Vaccine for Preventing Recurrence After Surgery in Epithelial Ovarian Cancer Patients

Led by Second Affiliated Hospital of Wenzhou Medical University · Updated on 2024-04-02

10

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying epithelial ovarian cancer EOC patients who have undergone surgery and test positive for minimal residual disease MRD using ctDNA monitoring. This trial aims to develop a new clinical system combining conventional treatments with personalized vaccines to prevent cancer recurrence after surgery. The study also focuses on creating a prediction method for tumor neoantigens and evaluating personalized neoantigen vaccine effectiveness to improve long-term patient outcomes. Participants receive a personalized neoantigen polypeptide vaccine made from 5 to 20 synthetic peptides. The vaccine is given by subcutaneous injection in multiple doses five doses in the first month days 1, 4, 8, 15, and 22 and two booster doses in the following months days 54 and 84. This approach is combined with standard postoperative treatment protocols and is being tested across several hospitals as part of a multi-center clinical study. During the study, patients will have regular follow-ups every three months for up to two years after surgery. These visits include blood tests for tumor markers CA125, HE4, CEA, CA199, imaging scans CT, PET-CT, MRI, ultrasound, and assessments of immune and safety parameters. Researchers will monitor overall response rate, progression-free survival, overall survival, and safety to evaluate the treatments impact on preventing cancer recurrence and improving survival prognosis.

CONDITIONS

Brief Title

Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC

Research Team

X

Xinxin Zhang, Master

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here